Scopolamine

莨菪碱

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameScopolamine
Drug Alias Name东莨菪碱HyoscineTRANSDERM SCOP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsDepressive DisorderMood DisordersBipolar Disorder +[8] 
Global Approved IndicationsMotion SicknessPostoperative Nausea and Vomiting
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesNational University Of Ireland, GalwayStanley Medical Research InstituteBaxter Healthcare Corp
Inactive CompaniesGlaxosmithkline PlcRepurposed Therapeutics IncNational Institute On Aging (NIA) +[6] 
Active IndicationsBipolar DisorderMotion SicknessPostoperative Nausea and Vomiting
Inactive IndicationsDepressive DisorderMood DisordersPhobia, Social +[5] 

Other Information

ATC CodeA04AD01N05CM05S01FA02
Related LinksWikipediaDrugBankKEGG